tradingkey.logo
tradingkey.logo
Search

Gyre Therapeutics Announces NMPA Approval For Clinical Trial Evaluating Pirfenidone Capsules In Oncology-Related Pulmonary Complications

ReutersMar 31, 2025 11:14 AM
facebooktwitterlinkedin

- Gyre Therapeutics Inc GYRE.O:

  • GYRE THERAPEUTICS ANNOUNCES NMPA APPROVAL FOR CLINICAL TRIAL EVALUATING PIRFENIDONE CAPSULES IN ONCOLOGY-RELATED PULMONARY COMPLICATIONS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI